1. World Heath Organization. (2019). Global Tuberculosis Report. https://www.who.int/publications/i/item/9789241565714.
2. The Working Group of New TB Drugs Global TB New Drug Pipeline. https://www.newtbdrugs.org/pipeline/clinical.
3. Linezolid for XDR-TB--final study outcomes;Lee;N. Engl. J. Med.,2015
4. Treatment of highly drug-resistant pulmonary tuberculosis;Conradie;N. Engl. J. Med.,2020
5. National Institute of Health. Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNix). https://clinicaltrials.gov/ct2/show/NCT03086486.